{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:34:16Z","timestamp":1788975256933,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Hellenic Cooperative Oncology Group","award":["HE_R_6OX\/06"],"award-info":[{"award-number":["HE_R_6OX\/06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12883-016-0710-4","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T21:05:04Z","timestamp":1475269504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer"],"prefix":"10.1186","volume":"16","author":[{"given":"Emmanouil V.","family":"Dermitzakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios K.","family":"Kimiskidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Lazaridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoi","family":"Alexopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Timotheadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Papanikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania","family":"Romanidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Georgiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantine T.","family":"Kalogeras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iakovos","family":"Tsiptsios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil","family":"Tarlatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Fountzilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,1]]},"reference":[{"issue":"1","key":"710_CR1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.critrevonc.2011.04.012","volume":"82","author":"AA Argyriou","year":"2012","unstructured":"Argyriou AA, Bruna J, Marmiroli P, Cavaletti G. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol. 2012;82(1):51\u201377.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10","key":"710_CR2","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1200\/JCO.2005.04.0543","volume":"24","author":"JJ Lee","year":"2006","unstructured":"Lee JJ, Swain SM. Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol. 2006;24(10):1633\u201342.","journal-title":"J Clin Oncol"},{"issue":"4 Suppl 3","key":"710_CR3","first-page":"1","volume":"20","author":"EK Rowinsky","year":"1993","unstructured":"Rowinsky EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC. Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol. 1993;20(4 Suppl 3):1\u201315.","journal-title":"Semin Oncol"},{"issue":"3","key":"710_CR4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1212\/WNL.39.3.368","volume":"39","author":"RB Lipton","year":"1989","unstructured":"Lipton RB, Apfel SC, Dutcher JP, Rosenberg R, Kaplan J, Berger A, Einzig AI, Wiernik P, Schaumburg HH. Taxol produces a predominantly sensory neuropathy. Neurology. 1989;39(3):368\u201373.","journal-title":"Neurology"},{"issue":"11","key":"710_CR5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1023\/A:1013184301155","volume":"12","author":"G Fountzilas","year":"2001","unstructured":"Fountzilas G, Tsavdaridis D, Kalogera-Fountzila A, Christodoulou CH, Timotheadou E, Kalofonos CH, Kosmidis P, Adamou A, Papakostas P, Gogas H, et al. Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II study. Ann Oncol. 2001;12(11):1545\u201351.","journal-title":"Ann Oncol"},{"issue":"10","key":"710_CR6","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1200\/JCO.1998.16.10.3353","volume":"16","author":"AD Seidman","year":"1998","unstructured":"Seidman AD, Hudis CA, Albanell J, Tong W, Tepler I, Currie V, Moynahan ME, Theodoulou M, Gollub M, Baselga J, et al. Dose-dense therapy with weekly 1-h paclitaxel infusions in the treatment of metastatic breast cancer. J Clin Oncol. 1998;16(10):3353\u201361.","journal-title":"J Clin Oncol"},{"issue":"22","key":"710_CR7","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1200\/JCO.2001.19.22.4216","volume":"19","author":"EA Perez","year":"2001","unstructured":"Perez EA, Vogel CL, Irwin DH, Kirshner JJ, Patel R. Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer. J Clin Oncol. 2001;19(22):4216\u201323.","journal-title":"J Clin Oncol"},{"issue":"1","key":"710_CR8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ncl.2007.01.001","volume":"25","author":"R Freeman","year":"2007","unstructured":"Freeman R. Autonomic peripheral neuropathy. Neurol Clin. 2007;25(1):277\u2013301.","journal-title":"Neurol Clin"},{"issue":"12","key":"710_CR9","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/ene.12514","volume":"21","author":"EV Dermitzakis","year":"2014","unstructured":"Dermitzakis EV, Kimiskidis VK, Eleftheraki A, Lazaridis G, Konstantis A, Basdanis G, Tsiptsios I, Georgiadis G, Fountzilas G. The impact of oxaliplatin-based chemotherapy for colorectal cancer on the autonomous nervous system. Eur J Neurol. 2014;21(12):1471\u20137.","journal-title":"Eur J Neurol"},{"issue":"2","key":"710_CR10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF02291236","volume":"6","author":"H Kaufmann","year":"1996","unstructured":"Kaufmann H. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Clin Auton Res. 1996;6(2):125\u20136.","journal-title":"Clin Auton Res"},{"key":"710_CR11","unstructured":"Assessment: Clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1996;46(3):873\u201380."},{"issue":"2","key":"710_CR12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02295996","volume":"12","author":"NQ Mc","year":"1947","unstructured":"Mc NQ. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika. 1947;12(2):153\u20137.","journal-title":"Psychometrika"},{"issue":"6","key":"710_CR13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2307\/3001968","volume":"1","author":"F Wilcoxon","year":"1945","unstructured":"Wilcoxon F. Individual comparisons by ranking methods. Biom Bull. 1945;1(6):80\u20133.","journal-title":"Biom Bull"},{"issue":"1","key":"710_CR14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1214\/aoms\/1177730491","volume":"18","author":"HW Mann","year":"1947","unstructured":"Mann HW, Whitney DR. On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other. Ann Math Stat. 1947;18(1):50\u201360.","journal-title":"Ann Math Stat"},{"issue":"15","key":"710_CR15","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","volume":"332","author":"EK Rowinsky","year":"1995","unstructured":"Rowinsky EK, Donehower RC. Paclitaxel (taxol). N Engl J Med. 1995;332(15):1004\u201314.","journal-title":"N Engl J Med"},{"issue":"8","key":"710_CR16","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.yexcr.2007.02.007","volume":"313","author":"L Pentassuglia","year":"2007","unstructured":"Pentassuglia L, Timolati F, Seifriz F, Abudukadier K, Suter TM, Zuppinger C. Inhibition of ErbB2\/neuregulin signaling augments paclitaxel-induced cardiotoxicity in adult ventricular myocytes. Exp Cell Res. 2007;313(8):1588\u2013601.","journal-title":"Exp Cell Res"},{"issue":"2","key":"710_CR17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/CAD.0b013e328011335e","volume":"18","author":"C Nistico","year":"2007","unstructured":"Nistico C, Bria E, Cuppone F, Carpino A, Ferretti G, Vitelli G, Sperduti I, Calabretta F, Toglia G, Tomao S, et al. Troponin-T and myoglobin plus echocardiographic evaluation for monitoring early cardiotoxicity of weekly epirubicin-paclitaxel in metastatic breast cancer patients. Anti-Cancer Drugs. 2007;18(2):227\u201332.","journal-title":"Anti-Cancer Drugs"},{"issue":"11","key":"710_CR18","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1200\/JCO.1999.17.11.3596","volume":"17","author":"A Gennari","year":"1999","unstructured":"Gennari A, Salvadori B, Donati S, Bengala C, Orlandini C, Danesi R, Del Tacca M, Bruzzi P, Conte PF. Cardiotoxicity of epirubicin\/paclitaxel-containing regimens: role of cardiac risk factors. J Clin Oncol. 1999;17(11):3596\u2013602.","journal-title":"J Clin Oncol"},{"issue":"1","key":"710_CR19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/cncr.10914","volume":"97","author":"L Biganzoli","year":"2003","unstructured":"Biganzoli L, Cufer T, Bruning P, Coleman RE, Duchateau L, Rapoport B, Nooij M, Delhaye F, Miles D, Sulkes A, et al. Doxorubicin-paclitaxel: a safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European Organization for Research and Treatment of Cancer multicenter trial. Cancer. 2003;97(1):40\u20135.","journal-title":"Cancer"},{"issue":"7","key":"710_CR20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.annonc.a010717","volume":"7","author":"J Gehl","year":"1996","unstructured":"Gehl J, Boesgaard M, Paaske T, Vittrup Jensen B, Dombernowsky P. Combined doxorubicin and paclitaxel in advanced breast cancer: effective and cardiotoxic. Ann Oncol. 1996;7(7):687\u201393.","journal-title":"Ann Oncol"},{"issue":"1","key":"710_CR21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1124\/jpet.106.103846","volume":"318","author":"E Salvatorelli","year":"2006","unstructured":"Salvatorelli E, Menna P, Cascegna S, Liberi G, Calafiore AM, Gianni L, Minotti G. Paclitaxel and docetaxel stimulation of doxorubicinol formation in the human heart: implications for cardiotoxicity of doxorubicin-taxane chemotherapies. J Pharmacol Exp Ther. 2006;318(1):424\u201333.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"710_CR22","first-page":"1511","volume":"7","author":"G Minotti","year":"2001","unstructured":"Minotti G, Saponiero A, Licata S, Menna P, Calafiore AM, Teodori G, Gianni L. Paclitaxel and docetaxel enhance the metabolism of doxorubicin to toxic species in human myocardium. Clin Cancer Res. 2001;7(6):1511\u20135.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"710_CR23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/echo.12621","volume":"32","author":"C Altin","year":"2015","unstructured":"Altin C, Sade LE, Demirtas S, Karacaglar E, Kanyilmaz S, Simsek V, Ayhan A, Muderrisoglu H. Effects of Paclitaxel and Carboplatin combination on mechanical myocardial and microvascular functions: a transthoracic Doppler echocardiography and two-dimensional strain imaging study. Echocardiography. 2015;32(2):238\u201347.","journal-title":"Echocardiography"},{"issue":"2","key":"710_CR24","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3892\/ol.2011.501","volume":"3","author":"H Sasaki","year":"2012","unstructured":"Sasaki H, Yano M, Kawano O, Hikosaka Y, Fujii Y. Thymoma associated with fatal myocarditis and polymyositis in a 58-year-old man following treatment with carboplatin and paclitaxel: A case report. Oncol Lett. 2012;3(2):300\u20132.","journal-title":"Oncol Lett"},{"issue":"1","key":"710_CR25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.radonc.2014.12.005","volume":"114","author":"N Haj Mohammad","year":"2015","unstructured":"Haj Mohammad N, Kamphuis M, Hulshof MC, Lutkenhaus LJ, Gisbertz SS, Bergman JJ, de Bruin-Bon HA, Geijsen ED, Bel A, Boekholdt SM, et al. Reduction of heart volume during neoadjuvant chemoradiation in patients with resectable esophageal cancer. Radiother Oncol. 2015;114(1):91\u20135.","journal-title":"Radiother Oncol"},{"issue":"8","key":"710_CR26","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S1388-2457(00)00333-3","volume":"111","author":"HO Sener","year":"2000","unstructured":"Sener HO, Tascilar NF, Balaban H, Selcuki D. Sympathetic skin response in carpal tunnel syndrome. Clin Neurophysiol. 2000;111(8):1395\u20139.","journal-title":"Clin Neurophysiol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-016-0710-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T01:19:42Z","timestamp":1568423982000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-016-0710-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["710"],"URL":"https:\/\/doi.org\/10.1186\/s12883-016-0710-4","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,1]]},"article-number":"190"}}